---
title: "Hyphens Pharma completes second tranche of Ardence Pharma acquisition"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239747194.md"
description: "Hyphens Pharma acquired an additional 17% stake.Hyphens Pharma International completed the second tranche of acquiring 17% of shares in Ardence Pharma on 9 May.The total consideration for the Tranche 2 Sale Shares, subject at the exchange rate of $1.00: RM3.25 was equivalent to $3.35m (RM10.9m).Following the transaction, Hyphens Pharma now holds an 82% stake in Ardence Pharma.The company will make further announcements as and when there are material developments on the proposed acquisition in due course."
datetime: "2025-05-12T03:01:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239747194.md)
  - [en](https://longbridge.com/en/news/239747194.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239747194.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/239747194.md) | [繁體中文](https://longbridge.com/zh-HK/news/239747194.md)


# Hyphens Pharma completes second tranche of Ardence Pharma acquisition

**Hyphens Pharma acquired an additional 17% stake.**

Hyphens Pharma International completed the second tranche of acquiring 17% of shares in Ardence Pharma on 9 May.

The total consideration for the Tranche 2 Sale Shares, subject at the exchange rate of $1.00: RM3.25 was equivalent to $3.35m (RM10.9m).

Following the transaction, Hyphens Pharma now holds an 82% stake in Ardence Pharma.

The company will make further announcements as and when there are material developments on the proposed acquisition in due course.

### Related Stocks

- [Hyphens Pharma International Limited (1J5.SG)](https://longbridge.com/en/quote/1J5.SG.md)

## Related News & Research

- [Nio Onvo L60 to add LiDAR version in shift from pure vision strategy](https://longbridge.com/en/news/279037327.md)
- [Maha Rashtra Apex Assigns ISIN for Rights Entitlements Ahead of Rights Issue](https://longbridge.com/en/news/279035403.md)
- [Dr. Reddy’s Flags Phase III Setback as Immutep Halts Key Lung Cancer Trial](https://longbridge.com/en/news/279076056.md)
- [Paper-Based Honeycomb Transit Packaging Market Forecast 2026-2036: Global Market to Reach USD 2.6 Billion by 2036 at 8.0% CAGR](https://longbridge.com/en/news/279036605.md)
- [Kweichow Moutai says director of finance detained by authorities](https://longbridge.com/en/news/279034604.md)